Medicinal cannabis: minimising harm in a changing landscape

Regulators have raised the alarm about soaring cannabis scripts, issuing new guidance in a bid to minimise patient harm and curb inappropriate prescribing. Kate Cowling reports on what’s happened—and what it means for pharmacists at the frontline. For the Australian Health Practitioner Regulatory Agency (Ahpra) and national boards, the numbers painted a grim picture: more